1. Home
  2. NRSN vs AIEV Comparison

NRSN vs AIEV Comparison

Compare NRSN & AIEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • AIEV
  • Stock Information
  • Founded
  • NRSN 2017
  • AIEV 2011
  • Country
  • NRSN Israel
  • AIEV United States
  • Employees
  • NRSN N/A
  • AIEV N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • AIEV Blank Checks
  • Sector
  • NRSN Health Care
  • AIEV Finance
  • Exchange
  • NRSN Nasdaq
  • AIEV Nasdaq
  • Market Cap
  • NRSN 26.3M
  • AIEV 25.8M
  • IPO Year
  • NRSN 2021
  • AIEV N/A
  • Fundamental
  • Price
  • NRSN $1.31
  • AIEV $0.30
  • Analyst Decision
  • NRSN
  • AIEV
  • Analyst Count
  • NRSN 0
  • AIEV 0
  • Target Price
  • NRSN N/A
  • AIEV N/A
  • AVG Volume (30 Days)
  • NRSN 181.1K
  • AIEV 89.2K
  • Earning Date
  • NRSN 11-26-2024
  • AIEV 11-19-2024
  • Dividend Yield
  • NRSN N/A
  • AIEV N/A
  • EPS Growth
  • NRSN N/A
  • AIEV N/A
  • EPS
  • NRSN N/A
  • AIEV N/A
  • Revenue
  • NRSN N/A
  • AIEV N/A
  • Revenue This Year
  • NRSN N/A
  • AIEV N/A
  • Revenue Next Year
  • NRSN N/A
  • AIEV N/A
  • P/E Ratio
  • NRSN N/A
  • AIEV N/A
  • Revenue Growth
  • NRSN N/A
  • AIEV N/A
  • 52 Week Low
  • NRSN $0.47
  • AIEV $0.30
  • 52 Week High
  • NRSN $2.33
  • AIEV $12.12
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 61.44
  • AIEV N/A
  • Support Level
  • NRSN $1.23
  • AIEV N/A
  • Resistance Level
  • NRSN $1.34
  • AIEV N/A
  • Average True Range (ATR)
  • NRSN 0.10
  • AIEV 0.00
  • MACD
  • NRSN 0.01
  • AIEV 0.00
  • Stochastic Oscillator
  • NRSN 75.00
  • AIEV 0.00

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About AIEV Thunder Power Holdings Inc. Common Stock

Thunder Power Holdings Inc is engaged in the design and development of high-performance electric vehicles.

Share on Social Networks: